Prospective Study Evaluating Management of Hypertension Induced by anti-VEGF Therapy in Patients with Active Cancer: VEGFHTN Trial

Authors

Otoniel Abraham Zelaya, The University of Texas MD Anderson Cancer CenterFollow
Noah Beinart, The University of Texas MD Anderson Cancer Center
Adam S. Potter, The University of Texas MD Anderson Cancer Center
Aung Naing, The University of Texas MD Anderson Cancer Center
Elizabeth Pierce, The University of Texas MD Anderson Cancer Center
Rebecca Caldwell, The University of Texas MD Anderson Cancer Center
Gaspar Pina, The University of Texas MD Anderson Cancer Center
Praise A. Oderinde, The University of Texas MD Anderson Cancer Center
Cezar Iliescu MD, The University of Texas MD Anderson Cancer Center
Efstratios Koutroumpakis, The University of Texas MD Anderson Cancer Center
Anita Deswal MD MPH, The University of Texas MD Anderson Cancer Center
Nicolas Palaskas MD, The University of Texas MD Anderson Cancer Center

Files

Program Affiliation

Partnership for Careers in Cancer Science and Medicine Summer Program

Keywords

Prospective, Anti-VEGF therapies, Hypertension

Recommended Citation

Zelaya, Otoniel Abraham; Beinart, Noah; Potter, Adam S.; Naing, Aung; Pierce, Elizabeth; Caldwell, Rebecca; Pina, Gaspar; Oderinde, Praise A.; Iliescu, Cezar MD; Koutroumpakis, Efstratios; Deswal, Anita MD MPH; and Palaskas, Nicolas MD, "Prospective Study Evaluating Management of Hypertension Induced by anti-VEGF Therapy in Patients with Active Cancer: VEGFHTN Trial" (2023). 2023 Summer Experience. 25.
https://openworks.mdanderson.org/sumexp23/25